ANNE COX: Open Payments
NPI 1467428268 · CORONADO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 36 payments from 12 companies in 2025. Trend: 2023 $2,676 · 2024 $3,051 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $143 |
| Neurocrine BioSciences, Inc. | 4 | $104 |
| Teva Pharmaceuticals USA, Inc. | 3 | $88 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Lundbeck LLC | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $56 |
| Indivior Inc. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
Products named: REXULTI, INGREZZA, UZEDY, Auvelity, CAPLYTA, COBENFY, SUBLOCADE, FANAPT.
Industry payments across CA — which companies pay providers there.
